Literature DB >> 28004205

Vascular alterations after photodynamic therapy mediated by 5-aminolevulinic acid in oral leukoplakia.

Flávia Cristina Perillo Rosin1, Ana Rita Ribeiro Barcessat2, Giuliana Gadoni Giovanni Borges1, Luciana Gonçalves Valente Ferreira1, Luciana Corrêa3.   

Abstract

Impairment of vascular functions after photodynamic therapy (PDT) is frequently associated with tumor remission and is considered one of the main antineoplastic PDT effects. Vascular alterations in oral leukoplakia (OL) treated with PDT have not yet been described. The aim of this study was to evaluate the effect of topical 5-ALA-mediated PDT on the vascular network of 4NQO-induced OL in rats. After applying 4NQO topically on the tongue during 16 weeks, there was induction of dysplastic lesions, which were treated with two PDT sessions (with an interval of 72 h between them), using topical application of 5-ALA and posterior irradiation with a laser (90 J/cm2 fluency). Histological sections of the tongues were obtained and analyzed concerning plasmatic exudation and microvessel density after immunolabeling with CD31 and CD34 vessel markers. There was intense plasmatic exudation after 6 h of the first PDT session; at 6 h of the second PDT session, there was a significant reduction in the density of CD31- and CD34-positive microvessels in comparison to controls (p < 0.05). In the PDT intervals, there was an increase in the density of CD31 and CD34 microvessels, suggesting angiogenesis. Topical application of 5-ALA-mediated PDT caused an immediate deleterious effect on the vascular network, increasing vessel permeability and reducing vessel density, mainly after two sessions of the treatment. However, secondary angiogenesis emerged in these lesions during intervals of the PDT session. This fact may be considered during the adoption of a PDT protocol, to avoid OL resistance and recurrence after the treatment.

Entities:  

Keywords:  5-Aminolevulinic acid; Angiogenesis; Microvessel density; Microvessel permeability; Oral premalignant lesion; Photodynamic therapy

Mesh:

Substances:

Year:  2016        PMID: 28004205     DOI: 10.1007/s10103-016-2127-0

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  29 in total

1.  Release of clotting factors from photosensitized endothelial cells: a possible trigger for blood vessel occlusion by photodynamic therapy.

Authors:  E Ben-Hur; E Heldman; S W Crane; I Rosenthal
Journal:  FEBS Lett       Date:  1988-08-15       Impact factor: 4.124

Review 2.  Effects of photodynamic therapy on tumor stroma.

Authors:  Qian Peng; Jahn M Nesland
Journal:  Ultrastruct Pathol       Date:  2004 Sep-Dec       Impact factor: 1.094

3.  Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration.

Authors:  Gaoyuan Cao; Christopher D O'Brien; Zhao Zhou; Samuel M Sanders; Jordan N Greenbaum; Antonis Makrigiannakis; Horace M DeLisser
Journal:  Am J Physiol Cell Physiol       Date:  2002-05       Impact factor: 4.249

Review 4.  Evaluation of microvascular density in tumors: pro and contra.

Authors:  Beatrice Nico; Vincenzo Benagiano; Domenica Mangieri; Nicola Maruotti; Angelo Vacca; Domenico Ribatti
Journal:  Histol Histopathol       Date:  2008-05       Impact factor: 2.303

Review 5.  Efficacy of photodynamic therapy in the management of oral premalignant lesions. A systematic review.

Authors:  Fahim Vohra; Abdulaziz A Al-Kheraif; Talat Qadri; Mohamed Ibrahim Abu Hassan; Asma Ahmed; Saman Warnakulasuriya; Fawad Javed
Journal:  Photodiagnosis Photodyn Ther       Date:  2014-10-12       Impact factor: 3.631

6.  Increase in protoporphyrin IX after 5-aminolevulinic acid based photodynamic therapy is due to local re-synthesis.

Authors:  Henriëtte S de Bruijn; Bastiaan Kruijt; Angélique van der Ploeg-van den Heuvel; Henricus J C M Sterenborg; Dominic J Robinson
Journal:  Photochem Photobiol Sci       Date:  2007-06-19       Impact factor: 3.982

7.  Topical hexylaminolevulinate and aminolevulinic acid photodynamic therapy: complete arteriole vasoconstriction occurs frequently and depends on protoporphyrin IX concentration in vessel wall.

Authors:  T A Middelburg; H S de Bruijn; L Tettero; A van der Ploeg van den Heuvel; H A M Neumann; E R M de Haas; D J Robinson
Journal:  J Photochem Photobiol B       Date:  2013-07-11       Impact factor: 6.252

8.  Topical photodynamic therapy using different porphyrin precursors leads to differences in vascular photosensitization and vascular damage in normal mouse skin.

Authors:  Tom A Middelburg; Hannah C de Vijlder; Henriette S de Bruijn; Angélique van der Ploeg-van den Heuvel; H A Martino Neumann; Ellen R M de Haas; Dominic J Robinson
Journal:  Photochem Photobiol       Date:  2014-04-07       Impact factor: 3.421

Review 9.  The effect of photodynamic therapy on tumor angiogenesis.

Authors:  Ramaswamy Bhuvaneswari; Yik Yuen Gan; Khee Chee Soo; Malini Olivo
Journal:  Cell Mol Life Sci       Date:  2009-03-31       Impact factor: 9.261

Review 10.  Oral potentially malignant disorders: is malignant transformation predictable and preventable?

Authors:  Isaäc van der Waal
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2014-07-01
View more
  1 in total

1.  Primary Clinical Evaluation of Photodynamic Therapy With Oral Leukoplakia in Chinese Patients.

Authors:  Ying Han; Si Xu; Jianqiu Jin; Xing Wang; Xiaodan Liu; Hong Hua; Xiaoyang Wang; Hongwei Liu
Journal:  Front Physiol       Date:  2019-01-22       Impact factor: 4.566

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.